Ronacaleret Hydrochloride

N/A

Report date: 2022/07/19 16:22:54
NME

Base Information

Drug NameRonacaleret Hydrochloride
Drug Alias NameRonacaleretum็ฝ—้‚ฃๅก็‘ž็›้…ธ็›ronacaleret็›้…ธ็ฝ—้‚ฃๅก็‘žๆด›ๅกๆฅ็‘ž็›้…ธ็› +[9]ย 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCalcium sensing receptor antagonists
TargetsCalcium sensing receptor
Therapy Area/IndicationsBone marrow transplant rejectionFractures, BoneOsteoporosis +[4]ย 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumUnited States +[21]ย 
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesShire Development Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline Plc
Active IndicationsN/A
Inactive IndicationsBone marrow transplant rejectionFractures, BoneOsteoporosis +[4]ย 

Other Information

ATC CodeN/A
Related LinksDrugBankKEGG